BioGaia AB (CHIX:BIOGBS) Cyclically Adjusted FCF per Share: kr2.96 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:BIOGBS BioGaia AB CHIX:BIOGBS
100 GF Score
Price kr120.20
GF Value kr129.35
! 3 Warning Signs
View Full Analysis

What is BioGaia AB Cyclically Adjusted FCF per Share?

BioGaia AB CHIX:BIOGBS 100 Cyclically Adjusted FCF per Share is kr2.96 as of Jun. 2026. GuruFocus rates CHIX:BIOGBS with a GF Score™ of 100/100 and a GF Value™ of kr129.35. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

BioGaia AB's adjusted free cash flow per share for the three months ended in Jun. 2026 was kr0.382. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr2.96 for the trailing ten years ended in Jun. 2026.

During the past 12 months, BioGaia AB's average Cyclically Adjusted FCF Growth Rate was 7.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of BioGaia AB was 10.60% per year. The lowest was 6.10% per year. And the median was 8.30% per year.

As of today (2026-07-23), BioGaia AB's current stock price is kr120.20. BioGaia AB's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was kr2.96. BioGaia AB's Cyclically Adjusted Price-to-FCF of today is 40.61.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of BioGaia AB was 74.34. The lowest was 35.11. And the median was 47.32.


BioGaia AB  (CHIX:BIOGBs) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

BioGaia AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=120.20/2.96
=40.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of BioGaia AB was 74.34. The lowest was 35.11. And the median was 47.32.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


BioGaia AB Cyclically Adjusted FCF per Share Related Terms


BioGaia AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for BioGaia AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB Cyclically Adjusted FCF per Share Chart

BioGaia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.97 2.17 2.31 2.28 2.81

BioGaia AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.49 2.80 2.81 2.80 2.96

CHIX:BIOGBS vs ZTS, UTHR: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Cyclically Adjusted Price-to-FCF falls into.


CHIX:BIOGBS
100GF Score
BioGaia AB CHIX:BIOGBS
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioGaia AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioGaia AB's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.382/134.1100*134.1100
=0.382

Current CPI (Jun. 2026) = 134.1100.

BioGaia AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.601 101.138 0.797
201612 0.526 102.022 0.691
201703 0.893 102.022 1.174
201706 0.146 102.752 0.191
201709 0.436 103.279 0.566
201712 0.784 103.793 1.013
201803 0.459 103.962 0.592
201806 0.317 104.875 0.405
201809 0.833 105.679 1.057
201812 0.360 105.912 0.456
201903 0.358 105.886 0.453
201906 0.259 106.742 0.325
201909 0.611 107.214 0.764
201912 0.025 107.766 0.031
202003 0.798 106.563 1.004
202006 0.354 107.498 0.442
202009 0.599 107.635 0.746
202012 0.553 108.296 0.685
202103 0.405 108.360 0.501
202106 0.543 108.928 0.669
202109 0.655 110.338 0.796
202112 0.526 112.486 0.627
202203 0.871 114.825 1.017
202206 0.777 118.384 0.880
202209 0.423 122.296 0.464
202212 0.907 126.365 0.963
202303 0.962 127.042 1.016
202306 0.792 129.407 0.821
202309 0.892 130.224 0.919
202312 1.068 131.912 1.086
202403 0.427 132.205 0.433
202406 1.157 132.716 1.169
202409 0.962 132.304 0.975
202412 1.006 132.987 1.014
202503 0.346 132.825 0.349
202506 0.751 133.699 0.753
202509 1.079 133.480 1.084
202512 0.819 133.390 0.823
202603 0.683 133.560 0.686
202606 0.382 134.110 0.382

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr2.96 mean?
BioGaia AB (CHIX:BIOGBS) has a Cyclically Adjusted FCF per Share of kr2.96 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on BioGaia AB and its competitors.
Is BioGaia AB's Cyclically Adjusted FCF per Share too high?
BioGaia AB's current Cyclically Adjusted FCF per Share is kr2.96. Overall, BioGaia AB has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does BioGaia AB's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
BioGaia AB's Cyclically Adjusted FCF per Share of kr2.96 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on BioGaia AB and its competitors. BioGaia AB's current Cyclically Adjusted FCF per Share is kr2.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioGaia AB stock overvalued right now?
BioGaia AB (CHIX:BIOGBS) has a current Cyclically Adjusted FCF per Share of kr2.96. The stock's GF Value™ is kr129.35, compared to a current price of kr120.20 — trading 7.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is kr2.96. BioGaia AB's overall GF Score™ is 100/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For BioGaia AB (CHIX:BIOGBS), the current Cyclically Adjusted FCF per Share is kr2.96 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioGaia AB (CHIX:BIOGBS) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued. The current stock price of kr120.20 is trading 7.1% below its estimated GF Value™ of kr129.35.

Key valuation signals for CHIX:BIOGBS:

  • Cyclically Adjusted FCF per Share: kr2.96
  • GF Value™: kr129.35 vs. price of kr120.20 (7.1% below fair value)
  • GF Score™: 100/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BIOGBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioGaia AB Business Description

Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
100GF Score

Get the complete analysis for CHIX:BIOGBS

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr120.20
Price
kr129.35
GF Value